SPARK Hub Announces 2025 SPARK DEV Funding Awardees
Awards will accelerate pediatric-focused innovations aligned with U.S. health security priorities.
WASHINGTON, D.C., September 15, 2025
SPARK for Innovations in Pediatrics, a BARDA Accelerator Network (BAN) 2.0 hub, led by Children’s National Hospital, today announced three awardees for its 2025 SPARK DEV Funding program: Congruence Medical Solutions, Sibel Health, and WearableDose. The awards provide non-dilutive milestone-based funding support of $200,000 each, along with expert guidance to advance solutions that strengthen health security for pediatric populations.
“Each of these awardees is addressing a critical need for children’s health and national preparedness,” said Julia Finkel, Principal Investigator, SPARK Hub.
“We look forward to partnering with these teams to help accelerate their medical countermeasures to real-world impact.”
2025 SPARK DEV Awardees
Congruence Medical Solutions
Congruence Medical Solutions, LLC is engaged in the design, development and supply of innovative drug delivery device solutions addressing unmet, emerging and hard-to-solve problems in microliter dosing, injection of viscous/high dose drugs and minimizing drug waste at the point of injection.
Sibel Health
Sibel Health is an award-winning medical technology company with a mission to deliver Better Health Data for All®. Sibel Health is a leading provider of advanced monitoring solutions for patients of all ages in the home or hospital, and novel digital health solutions for the life science market.
WearableDose
WearableDose is transforming radiation therapy monitoring with a real-time, AI-powered wearable dosimeter. Its flexible, tissue-equivalent patch continuously tracks exposure and enables immediate adjustments, improving treatment accuracy and reducing harm to healthy tissue.
These awards are supported in whole or in part with federal funds from the U.S. Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority (BARDA).
About SPARK Hub
The Biomedical Advanced Research and Development Authority (BARDA), within the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS), advances medical countermeasures that prevent, prepare for, and respond to health security threats, including chemical, biological, radiological, and nuclear hazards, pandemic influenza, and emerging infectious diseases. The Special Populations Acceleration Research and Knowledge (SPARK) for Innovations in Pediatrics, a BARDA Accelerator Network 2.0 hub, led by Children’s National Hospital, focuses on technologies tailored to children and provides mentorship, resources, and funding to accelerate impact.